1. Latthe PM, Champaneria R, Khan KS. Dysmenorrhoea.Clin Evid (Online). 2011 Feb 21;2011. pii: 0813.
2. Chan WY,Hill JC.Determination of menstrural prostaglandin levels in
nondysmenorrheic and dysmenorrheic subjects prostaglandin.1978;36(2):365-375
3. Creatsas G,Deligeoroglou E,Zachari A,et al.Prostaglandins:PGF2 alpha,PGE2,6-keto-PGF1 alpha and TXB2 serum
levels in dysmenorrheic aldolescents before, during and after treatment with oral contraceptives.Eur J Obster Gynecol
Reprod Biol 1990;36(4):292-298
4. Abu JI,Konje JC.Leukotrienes in gynaecology:the hypothetical value of anti- Leukotrienes therapy in dysmenorrheal and
endometriosis.Hum Repord Update 2000;6(1)200-205
5. Biegmayer C,Hofer G,Kaniz C,Reinthaller A,Kopp B,Janisch H.Concenterations of various arachidonic acid
metaboltes in menstrual fluid are associated with menstrual pain and are influenced by hormonal
contraceptives.GynecolEndocrinol 1995;9(3);307-312
6. Marjoribanks J, Proctor M, Farquhar C, Derks RS. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD001751.
7. McCormick MC.The contribution of low birth weight to infant mortality and childhood morbidity.N Engl Med
1985;312(5):82-90
8. Goldenberg RL,Rouse DJ.The perevention of peremature birth N Engl Med 1998;339(4):313-320
9. Hack M,Fanaroff AA.Outcome of children of extremely low birth weight and gestational age in the 1990s.Early Hum
Dev 1999;53(2):193-218
10. Challis JRG.Mechanism of parturition and pere term labor.Obsetet Gynecol Surv 2000;55(3):650-660
11. Challis JR.Underestanding peretem birth.clin Invest Med 2001;24(2)60-67
12. Byrne B,Morrison J.Preterm birth. Clin Evid 2002;7(2):1310-1324
13. Kjell H,Jan HS,Anne LW.Preterm delivery, an overview.Acta Obstet Gynecol Scand 2003;82(3):687-704
14. Masseva A, Dimitrov A, Altankova I, Koycheva E, Nikolov A, Dukovski A, et al. Finding a developing intrauterine
infection in preterm birth by using classic and modern infection indices. Akush Ginekol (Sofiia). 2010;49(7):21-6.
15. Menon R, Fortunato SJ, Milne GL, Brou L, Carnevale C, Sanchez SC, et al. Amniotic fluid eicosanoids in preterm
and term births: effects of risk factors for spontaneous preterm labor. Obstet Gynecol. 2011 Jul;118(1):121-34.
16. Akerlund M.can primary dysmenorrhea be elevated by a vasopressin antagonist?Acta Obster Gynecol Scand
1987;66:459-461
17. Akerlund M, Bossmar T,Brouard R,et al.Receptor binding of oxytocin and vasopressin antagonists and inhibitory
effects on isolated myometrium from preterm and term pregnant women.BJOG 1999;106:1047-1053
18. Bosmar T, Akerlund M,Fantoni G,Maggi M,Szamatowics J, Laudanski T.Receptor-mediated uterine effects of
oxytocin and vasopressin in non-pregnant women.BJOG 1995;102:907-912
19. Akerlund M, Stromberg P,Forsling ML.Primary dysmenorrheal and vasopressin.BJOG 1979;86:484-487
20. Brouard R,Bossmar T,Fournie-LIoret D,Chassard D,Akerlund M.Effect of SR49059,an orally active V1a vasopressin
receptor antagonist,in the prevention of dysmenorrheal.BJOG 2000;107:614-619
21. Juang C,Chou P.at el. Primary dysmenorrhea and risk of preterm delivery.Am J Perinatol 2007;24(1):11-16
22. Ylikorkala O,Kujansuu E. Increased rate of primary dysmenorrheal in women with spontaneous premature
labor.Prostaglandins Med 1981;6(1):213-216 19- Akerlund M. Targeting the oxytocin
receptor to relax the myometrium. Expert Opin Ther Targets. 2006 Jun;10(3):423-7
23. Akerlund M. Involvement of oxytocin and vasopressin in the pathophysiology of preterm labor and primary
dysmenorrheal. Prog Brain Res. 2002;139:359-65.
24. lumsden MA, Baird DT.Intrauterine pressure in dysmenorrheal.Acta Obster Gynecol Scand 1985;6(2):213-216
25. Smith RP,Powell JR.Simultaneous and subjective evaluation of mecloenamate sodium in treatment of primary
dysmenorrheal.Am J Obstet Gynecol 1987;157(5):611-618
26. Felice P, Jerome F strassIII, Steven G Gabbe, Gerson Weiss. Preterm birth Mechanism, Mediators, Prediction,
Prevention and Interventions 1'th ed;2007.p.174